Kreps Edward Jay

CEO Edward Jay Kreps sold 270.2K shares of CFLT at $30.70 on 2026-02-20, reducing holdings by 47.2%, leaving 301.7K shares

Edward Jay Kreps, CEO of Confluent, sold 270.2K shares for $8.3M, reducing his equity stake by nearly half from 571.9K to 301.7K shares. This is a material reduction in CEO exposure to the company. Prior to this sale, Kreps executed five trades at CFLT over a three-month window (late November to mid-December 2025), all sells; the two December transactions show modest 30-day gains (1.1% and 1.6%) with outcomes not yet measurable at 90 days, while the three November sales posted strong 30-day and 90-day gains (27.7%–37.2%), indicating the stock rallied after those sales—a pattern inconsistent with well-timed selling. Confluent remains unprofitable ($-66.5M net income on $298.5M annual revenue growth of 21.1%), and at $30.70 the stock trades 7.8% below its 52-week high, suggesting the CEO is selling during a period of sideways-to-declining momentum following earlier strength. The frequency and scale of disposals warrants scrutiny into cash-needs versus conviction.

CEO Kreps sells 738,500 shares ($22.2M) across 2 tranches; stock up 28.6% (30d), 53.0% (90d)

Edward Jay Kreps, CEO of Confluent, executed 2 separate sales totaling 738,500 shares for $22,198,490.00, reducing his holdings from 1,077,867 shares to 339,367 shares (a -68.5% reduction in position). The transaction occurred at a blended average price of $30.06, while the current stock price stands at $29.96—less than 1% below execution price. This follows a period of strong momentum: the stock is up 28.6% over the past 30 days and up 53.0% over 90 days, though it remains 20.4% below its 52-week high of $37.65. At same-ticker level, Kreps' prior two measurable sales at CFLT (from late August and early September) were poorly timed, with positive returns of 8.8% and 17.7% at 30 days (indicating the stock rose after he sold). The company reported a net loss of $66,504,000 for its latest fiscal year despite revenue growth of 24.0%, presenting mixed operational fundamentals. The timing of this sale during a significant rally warrants attention to whether it reflects an internal assessment of current valuation relative to fundamentals.

Confluent CEO Kreps sells 37,707 shares for $837.2K as stock falls 44.1% from 52-week high; unprofitable company context

Edward Jay Kreps, Confluent's Chief Executive Officer, executed 2 separate sales totaling 37,707 shares for $837,203.01 on 2025-11-20, reducing his stake by 10.0% from 377,074 to 339,367 shares. The sales occurred at a blended average price of $22.20, while the stock currently trades at $21.06—44.1% below its 52-week high of $37.65 and down 7.6% over the past 30 days, though up 18.6% over 90 days. His prior 3 measurable same-ticker sells at CFLT all showed positive 90-day returns (ranging from +33.0% to +43.2%), meaning the stock rose after each sale—a pattern of poorly-timed exits at this specific company. Against this backdrop, Confluent remains unprofitable (net income of $-66,504,000.00 in the latest quarter) despite 24.0% annual revenue growth, adding material context to insider disposition during a period of significant stock depreciation.

CEO Kreps sold 232,500 CFLT shares at $23.53; stock now at $22.66, -39.8% from 52-week high.

CEO Edward Jay Kreps sold 232,500 shares at $23.53 on 2025-11-13, reducing holdings by 38.1% to 377,074 shares post-transaction. The sale price is 3.8% above the current market price of $22.66, which sits -39.8% from the 52-week high of $37.65. Notably, his prior five trades at CFLT show a mixed record: two of the three measurable 90-day outcomes were positive (+36.9% and +43.2%), meaning the stock rose after those sales—poorly timed outcomes for a seller. This current sale, occurring as the stock trades near the lower end of its 52-week range despite 90-day momentum of +30.4%, differs from his typical timing pattern at this ticker. Confluent remains unprofitable with net income of $-66,504,000.00 on revenue of $298,524,000.00, though the company achieved +24.0% annual revenue growth.

CFLT CEO Kreps sells 232,500 shares at $18.66 on 2025-09-04; now holds 377,074 shares (-38.1%)

Edward Jay Kreps, CFLT's Chief Executive Officer, sold 232,500 shares on 2025-09-04 at $18.66 per share for $4,338,450.00, reducing his post-transaction holdings to 377,074 shares (-38.1% from pre-transaction holdings of 609,574 shares). The sale occurred well below the 52-week high of $37.65 (-46.2% from peak), and notably only weeks after similar sales on 2025-08-20, 2025-08-14, and 2025-08-14, suggesting a concentrated selling period at CFLT. His prior two measurable sales at CFLT (2025-06-05) both proved well-timed at the 90-day mark with declines of -23.0% and -21.3%, consistent with his cross-ticker track record showing a 70.59% well-timed sell rate. However, the company remains unprofitable with net income of $-82.0M on revenue of $282.3M (latest quarter), despite annual revenue growth of +24.0%, creating a context where both the near-term selling pattern and fundamental weakness merit observation. Note: This filing involves a derivative-conversion transaction; reported shares-after in Table I do not represent the insider's complete position.

CEO Kreps sold 37,707 shares at $17.04; stock now $17.79 (-52.8% from 52-week high of $37.65).

Edward Jay Kreps, CEO of Confluent, sold 37,707 shares on 2025-08-20 at $17.04, reducing his holdings by 9.1% and netting $642,527.28. The timing follows a steep price collapse: Confluent has fallen 32.5% over 30 days and 18.5% over 90 days, now trading 52.8% below its 52-week high of $37.65. His prior trades at Confluent show 1 of 1 measurable 90-day outcomes as well-timed (the May 2025 sale preceded an 18.2% decline), but the company's fundamentals remain challenged—net income was -$82.0M despite $282.3M in quarterly revenue and 24.0% annual growth. The sale occurs in an environment of significant stock depreciation, yet without additional context on market conditions or strategic rationale, the material facts are the sale size, timing relative to price momentum, and the company's unprofitable status.

CEO Kreps sells 232,500 CFLT shares for $3,993,257.94; stock down 52.5% from 52-week high, unprofitable company.

Edward Jay Kreps, CEO of Confluent, executed 2 separate sales totaling 232,500 shares for $3,993,257.94 at blended average price of $17.18. The sales reduced his holdings by 33.9%, from 685.0K shares to 452.5K shares. Context is material: the stock has declined 29.6% over the past 30 days and 52.5% from its 52-week high of $37.65, while the company reported a net loss of $82.0M on $282.3M quarterly revenue and remains unprofitable on a full-year basis. Across his 5 prior sales at CFLT, Kreps' 90-day outcomes were consistently negative (ranging from -17.6% to -23.7%), indicating a pattern of sales preceding further declines at this ticker. The current sale occurs in a sharply deteriorating price environment and follows a historical pattern of well-timed exits at CFLT.

CEO Kreps sells 232,500 shares at blended $24.50; 2 transactions netting $5.7M; holdings decline -33.9% to 452.5K shares

Edward Jay Kreps sold 232,500 shares across 2 separate transactions on 2025-06-05 for a combined $5,695,178.10 at a blended average price of $24.50, reducing his holdings from 685.0K to 452.5K shares (-33.9%). His prior 5 trades at Confluent show a pattern of well-timed selling at the 90-day mark, with the 3 measurable 2025 sales preceding declines of -22.9%, -21.0%, and -17.6% respectively. This latest sale occurs as the stock trades -35.2% from its 52-week high, though it has recovered +18.1% over the past 30 days. Confluent remains unprofitable (full-year net income was negative) despite annual revenue growth of +24.0%, presenting a contrasting risk-reward signal that the market's recent recovery may not have fully reconciled.

CEO Edward Kreps sold 37.7K shares of CFLT at $21.84 on 2025-05-20, leaving 452.5K shares post-transaction.

CEO Edward Jay Kreps executed a sale of 37,707 shares at $21.84 on 2025-05-20, reducing his CFLT holdings by 7.7%. The stock has since fallen 41.9% from its 52-week high of $37.65, currently trading at $21.89, near the sale price. His same-ticker history at CFLT shows a pattern of recent frequent sales: five prior trades since February 2025, with measurable 30-day outcomes of -17.6%, -30.0%, -32.9%, and -34.5%, indicating consistent downward pressure following his sales. Confluent remains unprofitable on a full-year basis despite 24.0% annual revenue growth, with the latest quarter showing $271.1M in revenue but $-67.6M in net income. The sale occurs in the context of near-term downward momentum (90-day change: -29.4%) but follows a recent 30-day recovery of 6.1%, which may reflect tactical positioning rather than a broader conviction shift given the Company's ongoing losses.

CEO Edward Jay Kreps sold 23,500 CFLT shares at $22.67 (now $21.89); fifth consecutive sale in 2025 amid -37.4% 90-day decline.

Edward Jay Kreps, CEO of Confluent, sold 23,500 shares at $22.67 on 2025-05-15, the fifth discretionary sale within a 12-week window (four prior sales on 2025-03-06 and 2025-02-20). The stock has declined 37.4% over the past 90 days and currently trades 41.9% below its 52-week high of $37.65. Across his prior four same-ticker sales in 2025, all produced negative 30-day returns (-34.5%, -32.9%, -30.0%, -17.6%, -18.6%), establishing a pattern of selling into downtrends rather than upswings. The company remains unprofitable (net income of -$67.6M on quarterly revenue of $271.1M) despite 24.0% annual revenue growth, creating financial headwinds that may explain the sustained selling sequence. This sale is material not as a single transaction but as part of a sustained liquidation pattern by the company's top executive during a period of significant stock depreciation and operational losses.